ecm proteins Search Results


flat bottom 96 well cellvo matrix plus plates  (StemBioSys)
93
StemBioSys flat bottom 96 well cellvo matrix plus plates
Flat Bottom 96 Well Cellvo Matrix Plus Plates, supplied by StemBioSys, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flat bottom 96 well cellvo matrix plus plates/product/StemBioSys
Average 93 stars, based on 1 article reviews
flat bottom 96 well cellvo matrix plus plates - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
cellvotm chondromatrix coated plasticware  (StemBioSys)
99
StemBioSys cellvotm chondromatrix coated plasticware
Cellvotm Chondromatrix Coated Plasticware, supplied by StemBioSys, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cellvotm chondromatrix coated plasticware/product/StemBioSys
Average 99 stars, based on 1 article reviews
cellvotm chondromatrix coated plasticware - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
muscle really interesting new gene finger protein 1  (ECM Biosciences)
86
ECM Biosciences muscle really interesting new gene finger protein 1
Muscle Really Interesting New Gene Finger Protein 1, supplied by ECM Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/muscle really interesting new gene finger protein 1/product/ECM Biosciences
Average 86 stars, based on 1 article reviews
muscle really interesting new gene finger protein 1 - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
muscle atrophy f box atrogin 1  (ECM Biosciences)
91
ECM Biosciences muscle atrophy f box atrogin 1
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Muscle Atrophy F Box Atrogin 1, supplied by ECM Biosciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/muscle atrophy f box atrogin 1/product/ECM Biosciences
Average 91 stars, based on 1 article reviews
muscle atrophy f box atrogin 1 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
ecm proteins  (Autio Co Inc)
90
Autio Co Inc ecm proteins
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins, supplied by Autio Co Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins/product/Autio Co Inc
Average 90 stars, based on 1 article reviews
ecm proteins - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm proteins  (Kimble Inc)
90
Kimble Inc ecm proteins
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins, supplied by Kimble Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins/product/Kimble Inc
Average 90 stars, based on 1 article reviews
ecm proteins - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm microenvironment  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics ecm microenvironment
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Microenvironment, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm microenvironment/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
ecm microenvironment - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm proteins  (Cell Biolabs Inc)
90
Cell Biolabs Inc ecm proteins
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
ecm proteins - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm proteins  (Janssen)
90
Janssen ecm proteins
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins/product/Janssen
Average 90 stars, based on 1 article reviews
ecm proteins - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm proteins  (Sanyou Biopharmaceuticals Co Ltd)
90
Sanyou Biopharmaceuticals Co Ltd ecm proteins
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins, supplied by Sanyou Biopharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins/product/Sanyou Biopharmaceuticals Co Ltd
Average 90 stars, based on 1 article reviews
ecm proteins - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
inflammatory and ecm gene and protein arrays  (Qiagen)
90
Qiagen inflammatory and ecm gene and protein arrays
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Inflammatory And Ecm Gene And Protein Arrays, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inflammatory and ecm gene and protein arrays/product/Qiagen
Average 90 stars, based on 1 article reviews
inflammatory and ecm gene and protein arrays - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
ecm proteins agrn  (VANGL2 LTD)
90
VANGL2 LTD ecm proteins agrn
Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy <t>F-Box/Atrogin-1</t> <t>(MAFbx/Atrogin-1)</t> and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.
Ecm Proteins Agrn, supplied by VANGL2 LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ecm proteins agrn/product/VANGL2 LTD
Average 90 stars, based on 1 article reviews
ecm proteins agrn - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy F-Box/Atrogin-1 (MAFbx/Atrogin-1) and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.

Journal: Amino acids

Article Title: Short and long-term effects of leucine and branched-chain amino acid supplementation of a protein and energy reduced diet on muscle protein metabolism in neonatal pigs

doi: 10.1007/s00726-018-2572-0

Figure Lengend Snippet: Schematic representation of protein synthesis and degradation pathways in skeletal muscle. Briefly, insulin signals by activating the insulin receptor (IR) leading to protein kinase B activation (PKB). Upon activation, mTORC1 phosphorylates its downstream effectors, ribosomal protein S6 kinase 1 (S6K1) and eIF4E-binding protein-1 (4EBP1). Phosphorylated 4E-BP1 releases eIF4E from the inactive eIF4E·4E-BP1 complex to form the active eIF4G·eIF4E complex that binds to mRNA and initiates translation. Amino acid signaling toward protein synthesis is less well understood; nonetheless, the consensus is that amino acids activate substrates downstream of mTOR, leading also to an increase in protein translation initiation via S6K1 and eIF4G· eIF4E activation. Extracellular signal-regulated kinases 1 and 2 (ERK1/2) also activate the mTOR pathway in response to insulin and contractile activity. In addition, insulin inactivates the transcription factors of the forkhead box O (FOXO) family and AMP-activated protein kinase α (AMPKα), which in turn downregulates the transcription of the E3 ubiquitin ligases muscle Atrophy F-Box/Atrogin-1 (MAFbx/Atrogin-1) and muscle RING-finger protein-1 (MuRF1), decreasing overall protein degradation.

Article Snippet: Primary antibodies used were against ribosomal protein S6 kinase (S6K1 Thr 389 and total; Cell Signaling Technology; Beverly, MA, USA), eukaryotic initiation factor 4 (eIF4E)-binding protein-1 (4EBP1 Thr 70 and total; Cell Signaling Technology), insulin receptor substrate 1 (IRS1 Ser 1101 and total; Cell Signaling Technology), protein kinase B (PKB Ser 308 and total; Cell Signaling Technology), Na + -coupled neutral AA transporter 2 (SNAT2; Aviva Systems Biology, San Diego, CA, USA), L-type AA transporter 1 (LAT1; Thermo Scientific, Rockford, IL, USA), the AMP-activated protein kinase alpha (AMPKα Thr 172 and total; Cell Signaling Technology), muscle atrophy F-box/Atrogin-1 (ECM Biosciences, Versailles, KY, USA), muscle RING-finger protein 1 (MuRF1; R&D Systems, Minneapolis, MN, USA), forkhead box protein O1 (FOXO1 Ser 256 and total; Cell Signaling Technology), and extracellular signal-regulated kinases 1 and 2 (ERK1/2 Thr 202 /Tyr 204 and total; Cell Signaling Technology).

Techniques: Activation Assay, Binding Assay, Activity Assay

Abundance of total (T) and phosphorylated (P) levels of LAT1, SNAT2, AMPKα, FOXO1, MuRF1, and Atrogin-1 in skeletal muscle of piglets fed Control (CON), Restricted + BCAA (RBCAA), Restricted + Leu (RL), or Restricted (R) diets for 9 (n = 24) and 21 d (n = 22). The interactions Diet×Muscle×Day, Diet×Day and Diet×Muscle were not significant, so only the effect of Diet is shown. Values are least square means ± SE. abcP ≤ 0.05

Journal: Amino acids

Article Title: Short and long-term effects of leucine and branched-chain amino acid supplementation of a protein and energy reduced diet on muscle protein metabolism in neonatal pigs

doi: 10.1007/s00726-018-2572-0

Figure Lengend Snippet: Abundance of total (T) and phosphorylated (P) levels of LAT1, SNAT2, AMPKα, FOXO1, MuRF1, and Atrogin-1 in skeletal muscle of piglets fed Control (CON), Restricted + BCAA (RBCAA), Restricted + Leu (RL), or Restricted (R) diets for 9 (n = 24) and 21 d (n = 22). The interactions Diet×Muscle×Day, Diet×Day and Diet×Muscle were not significant, so only the effect of Diet is shown. Values are least square means ± SE. abcP ≤ 0.05

Article Snippet: Primary antibodies used were against ribosomal protein S6 kinase (S6K1 Thr 389 and total; Cell Signaling Technology; Beverly, MA, USA), eukaryotic initiation factor 4 (eIF4E)-binding protein-1 (4EBP1 Thr 70 and total; Cell Signaling Technology), insulin receptor substrate 1 (IRS1 Ser 1101 and total; Cell Signaling Technology), protein kinase B (PKB Ser 308 and total; Cell Signaling Technology), Na + -coupled neutral AA transporter 2 (SNAT2; Aviva Systems Biology, San Diego, CA, USA), L-type AA transporter 1 (LAT1; Thermo Scientific, Rockford, IL, USA), the AMP-activated protein kinase alpha (AMPKα Thr 172 and total; Cell Signaling Technology), muscle atrophy F-box/Atrogin-1 (ECM Biosciences, Versailles, KY, USA), muscle RING-finger protein 1 (MuRF1; R&D Systems, Minneapolis, MN, USA), forkhead box protein O1 (FOXO1 Ser 256 and total; Cell Signaling Technology), and extracellular signal-regulated kinases 1 and 2 (ERK1/2 Thr 202 /Tyr 204 and total; Cell Signaling Technology).

Techniques: